Drug Development Kickoff Meeting Agenda
This is a practical guide to building a kickoff meeting agenda for a drug development project — the agenda that aligns the team and stakeholders at project start, adapted to the realities of developing a pharmaceutical product through regulatory stages.
What a Kickoff Meeting Agenda is
A kickoff meeting agenda is the agenda that aligns the team and stakeholders at project start. For the full concept and how it works in general, see Kickoff Meeting. On a drug development project it plays the same role, tuned to this kind of work.
Why it matters for a Drug Development project
Drug Development projects live or die on developing a pharmaceutical product through regulatory stages. A well-built kickoff meeting agenda gives the team a shared, explicit reference for exactly that — reducing ambiguity, aligning stakeholders, and making problems visible early enough to act. Skipping it, or doing it generically, is how drug development projects drift into avoidable delay and cost.
What to include
- Purpose and objectives
- Scope and plan walkthrough
- Roles (RACI)
- Ways of working
- Next steps
Drug Development-specific considerations
Tailor the kickoff meeting agenda to the risks that most often derail drug development projects:
- Regulatory approval delays
- Trial/validation failures
- Strict GxP compliance
Example
On a real drug development project, the kickoff meeting agenda would be shaped by developing a pharmaceutical product through regulatory stages. In particular, it should explicitly account for the project’s biggest risks — regulatory approval delays, trial/validation failures, strict GxP compliance — rather than treating them as afterthoughts.